Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [Phase 1]
Phase 1 clinical trial update for UCAR T-cell therapy targeting CD19/BCMA in relapse/refractory autoimmune diseases. The study includes seve…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: IgG-4 Levels in Systemic Sclerosis
Completed clinical trial investigating IgG-4 levels in systemic sclerosis. The snippet provides status but does not include trial results.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial is evaluating UTAA91 Injection for relapsed/refractory autoimmune diseases. The study is not yet recruiting …
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial evaluating mycophenolate mofetil for systemic sclerosis with subclinical interstitial lung disease is currently rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-08Clinical Trial Update: Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic Sclerosis [Phase 2]
A Phase 2 trial of pyridostigmine for dysphagia in systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis [Phase 1]
The update outlines a Phase 1 study to assess the safety of intravenous infusion of cultured allogeneic umbilical cord–derived mesenchymal s…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients [Phase 2]
Phase 2 trial evaluating the safety and tolerability of oral Ixazomib in scleroderma-related lung disease was terminated, with results poste…
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc) [Phase 1]
A Phase 1 study of TAK-007 in adults with refractory lupus nephritis or refractory systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating subcutaneous sodium thiosulfate for ectopic calcifications associated with systemic sclerosis and dermatomy…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
A pilot study evaluating early diagnosis of systemic sclerosis in a general rheumatology clinic has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Apollo Device for Fatigue in Systemic Sclerosis [NA]
A completed clinical trial evaluated the Apollo Device for fatigue in systemic sclerosis. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: MRI for Screening and Monitoring Scleroderma ILD
An update on a clinical trial evaluating MRI for screening and monitoring interstitial lung disease in systemic sclerosis (scleroderma), spo…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
An ongoing trial is evaluating home-based clinical management of cardiac complications in systemic sclerosis, including pulmonary arterial h…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Klotho and Mineral Bone Density in Systemic Sclerosis
Completed clinical trial evaluating the relationship between Klotho and mineral bone density in systemic sclerosis.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases [NA]
A clinical trial is planned to evaluate CD7 CAR-T cells for relapsed/refractory autoimmune diseases, specifically systemic sclerosis, with r…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Chester Step Test: is It Effective in Scleroderma Patients? [NA]
This clinical trial update reports a study evaluating whether the Chester Step Test is effective in people with systemic sclerosis (sclerode…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Effectiveness of Cannabinoids on Appetite in Scleroderma [Phase 3]
A Phase 3 clinical trial evaluated cannabinoids for improving appetite in individuals with systemic sclerosis and related malnutrition, and …
-
CLINICAL_TRIALS withdrawal · 2025-02-20Clinical Trial Update: CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating comprehensive phenotypic characterization of patients with scleroderma-associated interstitial lung disea…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Making it Work Program for Systemic Sclerosis [NA]
Clinical trial update indicates the study focused on systemic sclerosis (scleroderma) and has completed.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of universal CD19 CAR-T cells (UWD-CD19) with immunosuppressants for refractory auto…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis [Phase 2]
A Phase 2 clinical trial is investigating the efficacy and safety of Telitacicept for systemic sclerosis, focusing on the diffuse cutaneous …
-
CLINICAL_TRIALS withdrawal · 2025-02-04Clinical Trial Update: RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis [Phase 1]
A Phase 1 trial evaluating reduced-intensity conditioning allogeneic bone marrow transplant with post-transplant cyclophosphamide for refrac…